Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Interest Coverage Ratio (2016 - 2025)

Adma Biologics (ADMA) has disclosed Interest Coverage Ratio for 13 consecutive years, with 38.59 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 189.93% year-over-year to 38.59, compared with a TTM value of 26.93 through Dec 2025, up 169.87%, and an annual FY2025 reading of 26.93, up 169.87% over the prior year.
  • Interest Coverage Ratio was 38.59 for Q4 2025 at Adma Biologics, up from 30.45 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 38.59 in Q4 2025 and bottomed at 4.8 in Q2 2021.
  • Average Interest Coverage Ratio over 5 years is 6.36, with a median of 0.64 recorded in 2023.
  • The sharpest move saw Interest Coverage Ratio rose 1.97% in 2021, then soared 13899.99% in 2024.
  • Year by year, Interest Coverage Ratio stood at 3.98 in 2021, then soared by 73.45% to 1.06 in 2022, then skyrocketed by 316.85% to 2.29 in 2023, then soared by 481.24% to 13.31 in 2024, then surged by 189.93% to 38.59 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ADMA at 38.59 in Q4 2025, 30.45 in Q3 2025, and 23.34 in Q2 2025.